COMMUNIQUÉS West-GlobeNewswire

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
NEW YORK and WALTHAM, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 01, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Spyre Therapeutics Announces Grants of Inducement Awards
01/05/2026
WALTHAM, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to [...]
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
01/05/2026
MIAMI, May 01, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced that the U.S. [...]
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
CHARLESTOWN, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
DALLAS, May 01, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
01/05/2026
- Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth of 34% - - FDA approval anticipated with U.S. market availability of [...]
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
NEEDHAM, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
SAN DIEGO, May 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
VANCOUVER, British Columbia and BOSTON, MA, May 01, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development [...]
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
CAMBRIDGE, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core [...]
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
01/05/2026
BOSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]
Tstrive Review: A New Balanced Look at the Men’s Vitality and Energy Supplement
01/05/2026
NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- Low energy, slower metabolism, and a gradual drop in motivation are issues many men face with age or stress. Lifestyle changes such as better sleep and nutrition help, but some [...]
Derma Essential Claims Evaluated: Investigating the Ingredients Inside DermaEssential Healthy Skin Support Formula
01/05/2026
How Derma Essential's Biotin, Vitamin C, Zinc, and Horsetail Extract Formula Is Structured — Ingredients, Pricing, and Guarantee Explained for 2026 Largo, FL, May 01, 2026 (GLOBE NEWSWIRE) -- These statements have not [...]
Gala GLP-1 Weight Loss Claims Evaluated: The Most Trusted GLP1 Tirzepetide Telehealth Prescription Treatment & Tracker Provider
01/05/2026
How Gala GLP-1's Compounded Tirzepatide and Semaglutide Telehealth Plans Work: Licensed Providers, $179/Mo Pricing, No Insurance Required, and Access in All 50 States in 2026 Wilmington, Delaware, May 01, 2026 (GLOBE [...]
What Happens After the Breakthrough: At KFSH, Innovation Is Measured by Repetition
01/05/2026
RIYADH, Saudi Arabia, May 01, 2026 (GLOBE NEWSWIRE) -- Medical breakthroughs are often measured by what is achieved once. At King Faisal Specialist Hospital and Research Centre (KFSH), the more relevant question has [...]
HNL Lab Medicine Invites K–8 Students to Dream Up Their Greatest Scientific Discovery in Annual Art Contest
01/05/2026
Local students challenged to imagine and illustrate their own scientific experiment ALLENTOWN, Pa., May 01, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine has announced its Annual Art Contest, open to students in grades K–8 [...]
Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
01/05/2026
– VEPPANU ™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader – – Approval received in advance of FDA-assigned PDUFA date of June 5, 2026; Arvinas and Pfizer remain on track to [...]
Confluent Medical Technologies Names Tom Testa as Chief Operating Officer
01/05/2026
SCOTTSDALE, Ariz., May 01, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, Inc. (“Confluent”), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components [...]

Pages